Savvy Psychopharmacology

Managing procedural pain in a patient taking naltrexone

Author and Disclosure Information

 

References

Nonopioid analgesic agents

For a patient receiving naltrexone who needs to undergo a procedure, a multi­disciplinary consultation between the patient’s psychiatrist and other clinicians is key for providing a regimen that is safe and effective. A nonopioid analgesic agent may be considered to avoid the problematic interactions possible in these patients (Table 23-5). Nonopioid regimens can be utilized alone or in combination, and may include the following3-5:

Ketamine is a non-competitive antagonist at the N-methyl-d-aspartate receptor that can provide sedation and analgesia with a rapid onset and short duration of action. However, analgesics should still be used for patients undergoing procedures that might cause visceral pain. Ketamine is contraindicated for patients with uncontrolled hypertension.

Dexmedetomidine is an alpha-2 agonist that can provide sedative and analgesic effects. It can cause procedural hypotension and bradycardia, so caution is advised in patients with cardiac disease and hepatic and/or renal insufficiencies.

Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or ketorolac, inhibit cyclooxygenase enzymes and can be considered in analgesic regimens. However, for most surgical procedures, the increased risk of bleeding due to platelet inhibition is a concern.

Nonopioid options for managing procedural pain

Continue to: Acetaminophen

Recommended Reading

FDA approves Cassipa for opioid dependence
MDedge Psychiatry
Medically-treated youths more likely to stay in opioid addiction treatment
MDedge Psychiatry
FDA warns kratom vendors about unproven claims
MDedge Psychiatry
More than half of urine drug screens showed improper medication use
MDedge Psychiatry
Inpatient vs. outpatient addiction treatment: Which is best?
MDedge Psychiatry
Half as many people are trying heroin, but marijuana use grows
MDedge Psychiatry
FDA issues new REMS for immediate-release opioids
MDedge Psychiatry
Confirmed: Growth in overdose deaths is exponential
MDedge Psychiatry
Cannabinoids may raise pain tolerance, not relieve pain itself
MDedge Psychiatry
Signs point to growing abuse of gabapentinoids in the U.S.
MDedge Psychiatry